Filter News
Area of Research
- (-) Fusion and Fission (1)
- (-) Neutron Science (12)
- Biological Systems (1)
- Biology and Environment (56)
- Biology and Soft Matter (1)
- Clean Energy (27)
- Climate and Environmental Systems (2)
- Computational Biology (2)
- Computational Engineering (2)
- Isotopes (7)
- Materials (12)
- Materials for Computing (3)
- Mathematics (1)
- National Security (7)
- Nuclear Science and Technology (2)
- Supercomputing (34)
News Topics
- (-) Biomedical (12)
- (-) Climate Change (1)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (7)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (7)
- Biology (5)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (6)
- Clean Water (2)
- Composites (2)
- Computer Science (14)
- Coronavirus (8)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (4)
- Education (1)
- Energy Storage (10)
- Environment (10)
- Exascale Computing (1)
- Fossil Energy (2)
- Frontier (2)
- Fusion (22)
- Grid (2)
- High-Performance Computing (4)
- Isotopes (1)
- ITER (6)
- Machine Learning (3)
- Materials (14)
- Materials Science (24)
- Mathematics (1)
- Microscopy (4)
- Nanotechnology (11)
- National Security (2)
- Net Zero (1)
- Neutron Science (100)
- Nuclear Energy (29)
- Partnerships (3)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (3)
- Simulation (3)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (6)
- Transportation (7)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.